From the Alaska Native Tribal Health Consortium, Anchorage, AK (RS, GD, SW, CM); University of Washington, School of Medicine, Alaska WWAMI, Anchorage, AK (SR); Southcentral Foundation, Anchorage, AK (MH, MH, JS, MH); Fairbanks Memorial Hospital, Fairbanks, AK (LB); Yukon Kuskokwim Health Corporation, Bethel, AK (JP); Yukon Kuskokwim Health Corporation, Bethel, Alaska (CD); Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada (HP); British Columbia Centre for Disease Control, Vancouver, BC, Canada (HP, AS); School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada (AS).
The Alaska Environmental Child Health Outcomes Program’s IDeA States Pediatric Clinical Trials Network (ECHO ISPCTN) site is funded by the National Institute of Health, NHLBI, [award UG1OD024944-02). Funding for chart reviews is through the NiH Clinical and Translational Research Program, G248-21-W8663.
Funding for chart reviews is through the NIH Clinical and Translational Research Program, U54GM115371.
The authors report no conflicts of interest.
Send correspondence to Rosalyn Singleton, MD, MPH, Alaska Native Tribal Health Consortium, 3900 Ambassador Dr. Suite 210, Anchorage, AK 99508. E-mail: [email protected], [email protected].
